Dilip Shantilal Shanghvi

Dilip Shanghvi, founder and managing director of Sun Pharmaceutical Industries, built India’s largest pharma company and one of the world’s leading generics producers. Born in Gujarat in 1955, he began in his father’s pharmacy business before launching Sun Pharma in 1983 with just ₹10,000. Initially focused on psychiatry products, he grew Sun Pharma through acquisitions, including Taro (Israel), Caraco (US), and the landmark Ranbaxy buyout in 2014. The company now operates in over 100 countries with 35,000 employees. Shanghvi’s net worth has exceeded $20 billion, though he remains low-profile and data-driven. His children, Aalok and Vidhi, hold senior roles in the company. A Padma Shri awardee, Shanghvi’s philanthropy supports healthcare, mental health, and disaster relief. He is widely respected as India’s pharma visionary.

Timeline

1983: Founds Sun Pharma with ₹10,000 in Gujarat.

1990s: Expands product portfolio; acquires Caraco (US).

2007: Acquires Taro (Israel).

2014: Acquires Ranbaxy, becoming India’s largest pharma company.

2020s: Sun Pharma operates in 100+ countries.